Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Taisheng Li and Xiaosheng Liu.
Taisheng Li
Connection Strength
1.806
Xiaosheng Liu
  1. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects. Front Immunol. 2020; 11:1660.
    View in: PubMed
    Score: 0.892
  2. Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:671443.
    View in: PubMed
    Score: 0.234
  3. High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:627844.
    View in: PubMed
    Score: 0.233
  4. Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness. Emerg Microbes Infect. 2020 Dec; 9(1):2315-2321.
    View in: PubMed
    Score: 0.229
  5. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Mar; 7(3):ofaa102.
    View in: PubMed
    Score: 0.218
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.